Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Helmijr JA"'
Autor:
Jongbloed EM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Helmijr JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Reinders MJT; Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands., van Marion R; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van IJcken WFJ; Erasmus Center for Biomics, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Konings IR; Department of Medical Oncology, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Makrodimitris S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. s.makrodimitris@erasmusmc.nl.; Delft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands. s.makrodimitris@erasmusmc.nl.
Publikováno v:
Scientific reports [Sci Rep] 2023 Jun 27; Vol. 13 (1), pp. 10424. Date of Electronic Publication: 2023 Jun 27.
Autor:
Eyck BM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Jansen MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Noordman BJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Atmodimedjo PN; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., van der Wilk BJ; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Helmijr JA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Mostert B; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Doukas M; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Wijnhoven BP; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Lagarde SM; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., van Lanschot JJB; Department of Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands., Dinjens WN; Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Jan; Vol. 259 (1), pp. 35-45. Date of Electronic Publication: 2022 Oct 31.
Autor:
Vitale SR; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Clinical and Experimental Medicine - Center for Experimental Oncology and Hematology, University of Catania, Catania, Italy., Helmijr JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Gerritsen M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Coban H; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van Dessel LF; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Beije N; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., van der Vlugt-Daane M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Vigneri P; Department of Clinical and Experimental Medicine - Center for Experimental Oncology and Hematology, University of Catania, Catania, Italy., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Dits N; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., van Royen ME; Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Jenster G; Department of Urology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Lolkema M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC, Room Be400, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl.
Publikováno v:
BMC cancer [BMC Cancer] 2021 Mar 24; Vol. 21 (1), pp. 315. Date of Electronic Publication: 2021 Mar 24.
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
Autor:
Zhang Y; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. y.zhang@lacdr.leidenuniv.nl., Wester L; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., He J; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Geiger T; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Moerkens M; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Siddappa R; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Helmijr JA; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Timmermans MM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Look MP; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., van Deurzen CHM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Pont C; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., de Graauw M; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Danen EHJ; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Berns EMJJ; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., Meerman JHN; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands., Jansen MPHM; Department of Medical Oncology and Cancer Genomic Netherlands, Rotterdam, The Netherlands., van de Water B; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. b.water@lacdr.leidenuniv.nl.
Publikováno v:
Oncogene [Oncogene] 2018 Apr; Vol. 37 (14), pp. 1869-1884. Date of Electronic Publication: 2018 Jan 22.
Autor:
Ramirez-Ardila D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: d.ramirezardila@erasmusmc.nl., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: a.timmermans@erasmusmc.nl., Helmijr JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: j.helmijr@erasmusmc.nl., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: j.martens@erasmusmc.nl., Berns EMJJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: p.berns@erasmusmc.nl., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. Electronic address: m.p.h.m.jansen@erasmusmc.nl.
Publikováno v:
Translational oncology [Transl Oncol] 2017 Oct; Vol. 10 (5), pp. 854-866. Date of Electronic Publication: 2017 Sep 05.